Retained Earnings (Accumulated Deficit) in USD of BIO-TECHNE Corp from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
BIO-TECHNE Corp quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q2 2010 to Q3 2025.
  • BIO-TECHNE Corp Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was $1.08B, a 19.3% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.08B -$259M -19.3% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $1.07B -$259M -19.6% 30 Jun 2025 10-Q 05 Nov 2025
Q1 2025 $1.2B -$101M -7.81% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $1.29B +$25.3M +2.01% 31 Dec 2024 10-Q 06 Feb 2025
Q3 2024 $1.34B +$13.6M +1.03% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 $1.33B +$15.8M +1.21% 30 Jun 2024 10-K 22 Aug 2025
Q1 2024 $1.3B +$51.1M +4.1% 31 Mar 2024 10-Q 06 May 2024
Q4 2023 $1.26B +$61.4M +5.12% 31 Dec 2023 10-Q 07 Feb 2024
Q3 2023 $1.33B +$165M +14.2% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $1.31B +$187M +16.6% 30 Jun 2023 10-K 22 Aug 2024
Q1 2023 $1.25B +$114M +10% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $1.2B +$54.3M +4.74% 31 Dec 2022 10-Q 07 Feb 2023
Q3 2022 $1.16B +$43.2M +3.86% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $1.12B +$37.5M +3.45% 30 Jun 2022 10-K 23 Aug 2023
Q1 2022 $1.13B +$44M +4.04% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $1.15B +$40.9M +3.7% 31 Dec 2021 10-Q 07 Feb 2022
Q3 2021 $1.12B +$46M +4.28% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $1.09B +$28M +2.65% 30 Jun 2021 10-K 24 Aug 2022
Q1 2021 $1.09B +$76.1M +7.51% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 $1.1B +$66M +6.35% 31 Dec 2020 10-Q 08 Feb 2021
Q3 2020 $1.07B +$142M +15.2% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $1.06B +$126M +13.5% 30 Jun 2020 10-K 25 Aug 2021
Q1 2020 $1.01B +$84.9M +9.16% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $1.04B +$144M +16% 31 Dec 2019 10-Q 06 Feb 2020
Q3 2019 $931M +$26.2M +2.9% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $932M +$55M +6.27% 30 Jun 2019 10-K 26 Aug 2020
Q1 2019 $928M +$80.5M +9.5% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $895M +$55.6M +6.63% 31 Dec 2018 10-Q 07 Feb 2019
Q3 2018 $905M +$103M +12.8% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 $877M +$77.9M +9.75% 30 Jun 2018 10-K/A 06 Nov 2019
Q1 2018 $847M +$68.5M +8.79% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 $840M +$70.6M +9.18% 31 Dec 2017 10-Q 08 Feb 2018
Q3 2017 $802M +$27.7M +3.58% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $799M +$28.5M +3.7% 30 Jun 2017 10-K 27 Aug 2018
Q1 2017 $779M +$21.9M +2.9% 31 Mar 2017 10-Q 10 May 2017
Q4 2016 $769M +$30.5M +4.13% 31 Dec 2016 10-Q 09 Feb 2017
Q3 2016 $775M +$50.1M +6.92% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $771M +$56.7M +7.94% 30 Jun 2016 10-K 07 Sep 2017
Q1 2016 $757M +$57.5M +8.22% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $739M +$51.5M +7.49% 31 Dec 2015 10-Q 09 Feb 2016
Q3 2015 $725M +$58.9M +8.84% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $714M +$60.6M +9.27% 30 Jun 2015 10-K 29 Aug 2016
Q1 2015 $699M +$61.5M +9.65% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $687M +$69.3M +11.2% 31 Dec 2014 10-Q 09 Feb 2015
Q3 2014 $666M +$61.6M +10.2% 30 Sep 2014 10-Q 10 Nov 2014
Q2 2014 $653M +$65.6M +11.2% 30 Jun 2014 10-K 31 Aug 2015
Q1 2014 $638M +$65.7M +11.5% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $618M +$67.6M +12.3% 31 Dec 2013 10-Q 04 Feb 2014
Q3 2013 $604M +$68.3M +12.7% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $588M +$67.3M +12.9% 30 Jun 2013 10-K 29 Aug 2014
Q1 2013 $572M +$66.4M +13.1% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 $550M +$62.6M +12.8% 31 Dec 2012 10-Q 11 Feb 2013
Q3 2012 $536M +$56.3M +11.7% 30 Sep 2012 10-Q 09 Nov 2012
Q2 2012 $520M +$47.7M +10.1% 30 Jun 2012 10-K 29 Aug 2013
Q1 2012 $506M +$51.4M +11.3% 31 Mar 2012 10-Q 10 May 2012
Q4 2011 $488M +$54.1M +12.5% 31 Dec 2011 10-Q 07 Feb 2012
Q3 2011 $480M +$62.7M +15% 30 Sep 2011 10-Q 09 Nov 2011
Q2 2011 $473M +$72.6M +18.1% 30 Jun 2011 10-K 29 Aug 2012
Q1 2011 $454M 31 Mar 2011 10-Q 10 May 2011
Q4 2010 $433M 31 Dec 2010 10-Q 09 Feb 2011
Q3 2010 $417M 30 Sep 2010 10-Q 09 Nov 2010
Q2 2010 $400M 30 Jun 2010 10-K 29 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.